We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The New Variant Assessment Platform is working to improve genomic sequencing infrastructure across 9 countries and territories to help identify new variants.
The Joint Committee on Vaccination and Immunisation (JCVI) has provided interim advice to government regarding coronavirus (COVID-19) booster doses this autumn.
GAD provided detailed support and expertise to the government throughout the pandemic. As a result, we continued to embed new ways of working and supporting our clients.
Solomon Islands key health facilities on Malaita, Western and Choiseul provinces have been supported and equipped to respond to subsequent waves of COVID-19.
First published during the 2019 to 2022 Johnson Conservative government
G7 Foreign Ministers and the High Representative of the European Union endorsed an Action Plan on COVID-19 at their meeting in Germany in May 2022.
Latest UKHSA data shows increasing numbers coming forward for COVID-19 vaccine, but uptake continues to differ by ethnicity and areas of higher deprivation.
Latest UKHSA data shows 79.2% of those aged 75+ who became eligible at the end of March for coronavirus (COVID-19) booster have taken up the vaccine.
Government announces 113 charities benefited from voluntary, community and social enterprise grant fund.
A letter to responsible officers of exam boards to confirm the date when advance information should be published for November exams.
Use of the Moderna COVID-19 vaccine or ‘Spikevax’ has been approved for 6 to 11s after meeting the required safety, quality and effectiveness standards
An approval has been granted after the Valneva COVID-19 vaccine was found to meet the required safety, quality and effectiveness standards.
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study.
Findings from the final report of the government-backed REACT-1, one of the largest studies into coronavirus (COVID-19) infections in England, have been published today.
Frontline workers on COVID-19 response at Atoifi and Kilu’ufi hospitals in Malaita province attended a two-week training delivered by UK Emergency Medical Team.
The UK Health Security Agency (UKHSA) has today published updated guidance to support the next stage of the COVID-19 pandemic.
Government grant of £15.9 million awarded to chemical producer Croda to increase the UK’s capacity to manufacture key vaccine ingredients.
Letter issued to respond to requests for information from the general public regarding the ZOE COVID Study.
Information on who can access free coronavirus (COVID-19) tests from 1 April 2022 and how to get them.
New guidance outlines free COVID-19 tests will continue to be available to help protect specific groups once free testing for the general public ends on 1 April.
Latest UK Health Security Agency (UKHSA) data shows that 53.7% of pregnant women in England have been vaccinated with at least one dose of coronavirus (COVID-19) vaccine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).